• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Tobacco Products

  • Print
  • Share
  • E-mail
  • en Español en Español

Section 302 of the Tobacco Control Act - Study and Report

Return to Tobacco Control Act Main Page


On This Page

 

  1. Study. The Comptroller General of the United States shall conduct a study of cross-border trade in tobacco products to

    1. collect data on cross-border trade in tobacco products, including illicit trade and trade of counterfeit tobacco products and make recommendations on the monitoring of such trade;
       
    2. collect data on cross-border advertising (any advertising intended to be broadcast, transmitted, or distributed from the United States to another country) of tobacco products and make recommendations on how to prevent or eliminate, and what technologies could help facilitate the elimination of, cross-border advertising; and
       
    3. collect data on the health effects (particularly with respect to individuals under 18 years of age) resulting from cross-border trade in tobacco products, including the health effects resulting from--
      1. the illicit trade of tobacco products and the trade of counterfeit tobacco products; and
         
      2. the differing tax rates applicable to tobacco products.
         
       
  2. Report. Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the study described in subsection (a). 
     
  3. Definition. In this section:

    1. The term "cross-border trade" means trade across a border of the United States, a State or Territory, or Indian country.
       
    2. The term "Indian country" has the meaning given to such term in section 1151 of title 18, United States Code.
       
    3. The terms "State" and "Territory" have the meanings given to those terms in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321).